The Go-To Therapy for Vertigo and Balance Disorders

Effective Symptomatic Relief in Vestibular Disorders

Potent Calcium Channel Blocker & Antihistaminic Action

General Practitioners, ENT Specialists, and Neurologists

Secure a High-Volume, Chronic-Use Segment
Launch Your Cinnarizine 75 mg Monopoly Today!

Home/Products /cinnarizine-75-mg-tablet

Cinagrit 25 Tablet

Composition : Cinnarizine (75mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹0/-

Please Contact For Best Price

Cinagrit 75 Tablet (Cinnarizine 75 mg) is a selective calcium channel blocker and antihistamine that is widely prescribed for the symptomatic treatment of vertigo and associated symptoms like dizziness, tinnitus, nausea, and vomiting, particularly those related to Meniere's disease and travel sickness.

Key Commercial Value & Clinical Edge:

  • Dual Action: Cinnarizine's primary strength is its ability to inhibit calcium influx in the vestibular sensory cells, thereby reducing the excitability of the vestibular system, combined with a central antihistaminic H1 blocking action.

  • Broad Prescribability: It is highly valued by GPs and ENT specialists due to its efficacy in managing a wide range of balance-related disorders, which are highly prevalent in the geriatric population.

  • Chronic Use Potential: Vertigo and Meniere's disease often require long-term, continuous therapy, ensuring a consistent and reliable prescription flow and high customer retention.

  • Safety Profile: At this dose, it provides effective relief with manageable side effects, making it a reliable choice for long-term patient compliance.

Secure your exclusive Cinagrit 75 territory and capture the rapidly growing anti-vertigo market!

Read More

About the Product

Cinagrit 75 Tablet (Cinnarizine 75 mg) is a selective calcium channel blocker and antihistamine that is widely prescribed for the symptomatic treatment of vertigo and associated symptoms like dizziness, tinnitus, nausea, and vomiting, particularly those related to Meniere's disease and travel sickness.

Key Commercial Value & Clinical Edge:

  • Dual Action: Cinnarizine's primary strength is its ability to inhibit calcium influx in the vestibular sensory cells, thereby reducing the excitability of the vestibular system, combined with a central antihistaminic H1 blocking action.

  • Broad Prescribability: It is highly valued by GPs and ENT specialists due to its efficacy in managing a wide range of balance-related disorders, which are highly prevalent in the geriatric population.

  • Chronic Use Potential: Vertigo and Meniere's disease often require long-term, continuous therapy, ensuring a consistent and reliable prescription flow and high customer retention.

  • Safety Profile: At this dose, it provides effective relief with manageable side effects, making it a reliable choice for long-term patient compliance.

Secure your exclusive Cinagrit 75 territory and capture the rapidly growing anti-vertigo market!

Common side effects may include drowsiness, dry mouth, mild stomach upset, or weight gain. Occasionally, patients may experience fatigue or allergic reactions. These effects are generally mild and subside as the body adjusts to the medication. Avoid activities requiring alertness until you know how the medicine affects you.

Cinagrit 25 Tablet is indicated for the treatment and prevention of vertigo, motion sickness, Meniere’s disease, and other vestibular disorders causing dizziness, nausea, or imbalance. It helps in enhancing stability and comfort during travel and in patients with inner ear dysfunction.

Take Cinagrit 25 Tablet as directed by your doctor, preferably after meals to avoid stomach irritation. Avoid consuming alcohol or other sedatives while on this medication, as they may enhance drowsiness. Patients with liver disease or low blood pressure should use it cautiously. Do not exceed the prescribed dose, especially when driving or operating machinery.

Store Cinagrit 25 Tablet in a cool, dry place below 25°C, away from direct sunlight and moisture. Keep out of reach of children and use only within the expiry period printed on the pack.

Get in Touch